Dr. Lecia Sequist of Massachusetts General Hospital answers
questions about acquired resistance to EGFR tyrosine kinase
inhibitors and repeat biopsies of tumors over the course of
treatment for advanced NSCLC.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.